Immune Globulin Subcutaneous Solution

idgsc with rHuPH20 · Baxalta (now part of Shire)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Immune Globulin Subcutaneous Solution, covering 2016-05-26 to 2016-05-26. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PID [Phase 3]